GROWTH / DIRECT CATALOG PRICING
Sermorelin
Sermorelin is the amidated 1-29 fragment of human growth-hormone-releasing hormone (GHRH 1-29-NH2). The catalog does not state whether the material is the acetate salt.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 1
- Catalog class
- Growth
Choose a listed format
- 5 mg$37.00 · AvailableSelect format
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Sermorelin is the amidated 1-29 fragment of human growth-hormone-releasing hormone (GHRH 1-29-NH2). The catalog does not state whether the material is the acetate salt.
The growth classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Growth
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 1 format currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Sermorelin is the amidated 1-29 fragment of human growth-hormone-releasing hormone (GHRH 1-29-NH2). The catalog does not state whether the material is the acetate salt.
- Research covered
- A clinical diagnostic study administered sermorelin to 31 children previously treated for growth-hormone deficiency and measured acute growth-hormone responses. PubChem separately records sermorelin acetate as a defined substance.
- Important limit
- The study was a stimulation test in a selected pediatric population, not an evaluation of general use or the catalog's 5 mg material. Salt identity and lot-specific composition remain unverified.
FACTUAL FAQ
Sermorelin catalog questions
What formats are currently listed?
5 mg. Current price and stock state appear above.
What did researchers study?
A clinical diagnostic study administered sermorelin to 31 children previously treated for growth-hormone deficiency and measured acute growth-hormone responses. PubChem separately records sermorelin acetate as a defined substance.
What is the most important evidence limit?
The study was a stimulation test in a selected pediatric population, not an evaluation of general use or the catalog's 5 mg material. Salt identity and lot-specific composition remain unverified.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →